V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240015888 | 240014511 | 1.84 | 50.4 | Palliative (P) | 2016-01-05 | 2016-02-22 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 240012317 | TRIPLE INTRATHECAL |
| 240015889 | 240012663 | 1.6 | 95.3 | null | 2018-07-16 | 2018-09-10 | Topotecan (intravenous) | N | N | 240012325 | DABRAFENIB + TRAMETINIB |
| 240015890 | 240012667 | 1.57 | null | Palliative (P) | 2017-11-24 | 2017-12-27 | Liposomal Doxorubicin (Caelyx) | N | null | 240012479 | ERLOTINIB |
| 240015891 | 240008742 | null | 57.8 | Disease modification (D) | 2017-03-30 | 2017-04-07 | IPM | N | N | 240012886 | CYCLOPHOSPHAMIDE + DOCETAXEL + TRASTUZUMAB |
| 240015892 | 240008746 | 1.69 | null | Disease modification (D) | 2020-09-07 | 2020-09-10 | PONATINIB | 2 | null | 240013419 | NILOTINIB |
| 240015893 | 240008748 | 1.62 | null | Curative (C) | 2019-04-20 | 2019-04-21 | CARBOPLATIN + RT | N | N | 240013846 | RUXOLITINIB |
| 240015894 | 240008750 | 1.52 | 72 | Curative (C) | 2016-04-24 | 2016-05-02 | Cytarabine High Dose | 2 | N | 240013888 | DOXORUBICIN |
| 240015895 | 240008755 | 1.5 | 60 | Palliative (P) | 2018-10-01 | 2018-10-02 | IVAC | 2 | N | 240014317 | IVE |
| 240015896 | 240008763 | 1.77 | 82.2 | Disease modification (D) | 2017-09-24 | 2017-09-24 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 240014781 | R-EPOCH |
| 240015897 | 240008766 | 1.8 | 53.4 | Palliative (P) | 2016-06-26 | 2016-10-17 | BEVACIZUMAB + CARBO | N | N | 240015306 | ICE-R |
| 240015898 | 240008769 | 1.76 | null | Disease modification (D) | 2015-07-14 | 2015-09-29 | Cytarabine HD + Methotrexate HD | N | null | 240015521 | DOCETAXEL |
| 240015899 | 240015445 | 1.7 | 100.6 | Disease modification (D) | 2018-02-09 | 2018-02-16 | VINORELBINE | 02 | N | 240016012 | VEDEX |
| 240015900 | 240008779 | 1.79 | 84.2 | Palliative (P) | 2018-05-02 | 2018-06-01 | FCR IV - Cycle 2 onwards | N | N | 240016111 | MELPHALAN |
| 240015901 | 240012693 | 1.63 | 54.6 | Curative (C) | 2016-06-07 | 2016-07-05 | CLADRIBINE | N | null | 240016504 | ICE-R |
| 240015902 | 240008790 | 1.63 | null | Not known (9) | 2016-06-10 | 2016-06-10 | Nelarabine | N | N | 240017071 | CODOX M |
| 240015903 | 240012697 | null | 57 | Curative (C) | 2018-02-19 | 2018-02-25 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | N | N | 240017201 | VINORELBINE |
| 240015904 | 240008796 | 1.65 | null | Disease modification (D) | 2018-04-16 | 2018-04-17 | DA-EPOCH-R | N | N | 240017293 | LENALIDOMIDE + RITUXIMAB |
| 240015905 | 240008802 | null | 57 | Palliative (P) | 2018-04-24 | 2018-04-24 | GEM-P | 02 | N | 240017716 | CARBOPLATIN + EPIRUBICIN + PACLITAXEL |
| 240015906 | 240008806 | 1.63 | null | Palliative (P) | 2016-09-10 | 2016-09-12 | DA-EPOCH-R | null | N | 240018081 | DACTINOMYCIN + CYCLO + VINCRISTINE |
| 240015907 | 240012707 | 1.7 | null | Palliative (P) | 2018-11-06 | 2018-11-27 | Sorafenib | N | N | 240018715 | ERLOTINIB |
| 240015908 | 240008817 | 1.57 | 51 | Curative (C) | 2019-07-03 | 2019-07-04 | ALL UKALL60+ TRIAL | 02 | N | 240019224 | ESHAP R |
| 240015909 | 240016338 | null | null | Disease modification (D) | 2018-03-25 | 2018-04-02 | NHL 2003 Gp B COPADM 1 & 2 | N | null | 240019353 | CRIZOTINIB |
| 240015910 | 240008826 | 1.85 | 61 | Palliative (P) | 2020-02-17 | 2020-03-15 | Cytarabine HD + Rituximab | N | N | 240019968 | MYELOMA XI TRIAL |
| 240015911 | 240008828 | 1.55 | 96.8 | Disease modification (D) | 2018-02-14 | 2018-03-05 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + MESNA + RITUXIMAB | N | N | 240019983 | CRIZOTINIB |
| 240015912 | 240012717 | null | 51 | Palliative (P) | 2018-01-25 | 2018-08-16 | NHL 2003 Gp B COPADM 1 & 2 | Y | N | 240020386 | MPV |
| 240015913 | 240008843 | 1.71 | 49 | Palliative (P) | 2020-02-11 | 2020-03-03 | RCEOP | N | N | 240020689 | CTD |
| 240015914 | 240014547 | 1.68 | null | Disease modification (D) | 2015-10-29 | 2016-01-21 | CARBOPLATIN + RT | N | N | 240020856 | PMITCEBO-R |
| 240015915 | 240008859 | 1.45 | null | Palliative (P) | 2017-05-06 | 2017-05-09 | IVAC | 2 | N | 240021157 | CYTARABINE HD + METHOTREXATE HD |
| 240015916 | 240008861 | null | 84 | Palliative (P) | null | 2016-09-01 | Triple / Double Intrathecal Therapy | Y | N | 240021189 | ESHAP R |
| 240015917 | 240008863 | 1.7 | null | Palliative (P) | 2016-03-17 | 2016-03-17 | VINCRISTINE | 2 | N | 240021253 | VEDEX |
| 240015918 | 240008869 | 1.59 | 48.8 | Palliative (P) | 2017-06-23 | 2017-06-23 | GALLIUM TRIAL | N | N | 240021767 | IVE |
| 240015919 | 240008877 | 1.6 | 72 | Palliative (P) | 2013-12-06 | 2014-08-08 | VEDex | N | N | 240022028 | IVE |
| 240015920 | 240008882 | 1.64 | null | Palliative (P) | 2016-06-01 | 2016-06-01 | DOXORUBICIN | N | N | 240022121 | IGEV R |
| 240015921 | 240008890 | 1.68 | 44 | Curative (C) | 2013-03-09 | 2013-05-13 | Fludarabine + Melphalan RIC Allo | N | N | 240022512 | CARBOPLATIN + DOCETAXEL |
| 240015922 | 240008898 | null | 83.5 | Curative (C) | 2018-11-02 | 2018-12-30 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | N | N | 240022676 | CYTARABINE HIGH DOSE |
| 240015923 | 240008904 | null | 83 | Adjuvant (A) | null | 2018-02-16 | PACE-BOM | N | N | 240022998 | OXALIPLATIN + RALTITREXED |
| 240015924 | 240008906 | 1.54 | 97.6 | Disease modification (D) | 2016-04-29 | 2016-05-01 | PIXANTRONE | 02 | N | 240023081 | GALLIUM TRIAL |
| 240015925 | 240012760 | 1.75 | 89 | null | 2018-06-10 | 2018-06-22 | BORTEZOMIB + THALIDOMIDE | N | N | 240023200 | PEMETREXED |
| 240015926 | 240008913 | 1.74 | null | Disease modification (D) | 2018-02-24 | 2018-03-17 | PEMBROLIZUMAB | N | null | 240023657 | CYTARABINE HIGH DOSE |
| 240015927 | 240008917 | 1.74 | 79.5 | Curative (C) | 2018-07-12 | 2018-07-25 | GEM-P | 2 | N | 240023735 | CYTARABINE HD + METHOTREXATE HD |
| 240015928 | 240008921 | 1.52 | 45.8 | Curative (C) | 2015-02-11 | 2015-02-21 | IVAC | N | N | 240023752 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB |
| 240015929 | 240014566 | 1.81 | 68.2 | Curative (C) | 2016-08-03 | 2016-10-20 | Clofarabine + Cytarabine | N | Y | 240023933 | DHAP - R |
| 240015930 | 240008927 | 1.6 | 54 | Disease modification (D) | 2018-05-14 | 2018-05-14 | PIXANTRONE | 02 | N | 240024118 | CISPLATIN + GEMCITABINE |
| 240015931 | 240012784 | 1.65 | 92.6 | Disease modification (D) | 2019-05-24 | 2019-05-26 | CARMUSTINE + THIOTEPA | 02 | N | 240028943 | NHL 2003 |
| 240015932 | 240008971 | null | 58.4 | Not known (9) | 2018-11-13 | 2018-11-18 | AML17 TRIAL | 02 | N | 240030629 | CODOX M |
| 240015933 | 240012793 | null | 76 | Palliative (P) | 2016-02-19 | 2016-02-19 | BEVACIZUMAB + CARBO | 2 | N | 240030743 | GEMCITABINE + OXALIPLATIN + RITUXIMAB |
| 240015934 | 240015480 | 1.61 | 54.7 | Palliative (P) | 2017-04-12 | 2017-05-21 | Fludarabine + Melphalan RIC Allo | N | null | 240032004 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 240015935 | 240012800 | 1.75 | 63.4 | Disease modification (D) | 2015-09-27 | 2016-01-16 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 01 | N | 240032911 | FLAG |
| 240015936 | 240008986 | 1.61 | 76.6 | Curative (C) | 2015-12-04 | 2015-12-04 | TOPOTECAN | 2 | N | 240033328 | CAPECITABINE |
| 240015937 | 240009005 | 1.56 | 60 | Palliative (P) | 2018-03-03 | 2018-04-27 | Carboplatin + Topotecan | 02 | N | 240006774 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB |